Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin.

about

Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin.

Item

http://www.wikidata.org/entity/Q37471910

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Vildagliptin efficacy in combi ...... ely controlled with metformin.

@en

Vildagliptin efficacy in combi ...... ely controlled with metformin.

@nl

type

Item

label

Vildagliptin efficacy in combi ...... ely controlled with metformin.

@en

Vildagliptin efficacy in combi ...... ely controlled with metformin.

@nl

prefLabel

Vildagliptin efficacy in combi ...... ely controlled with metformin.

@en

Vildagliptin efficacy in combi ...... ely controlled with metformin.

@nl

P1476

Vildagliptin efficacy in combi ...... ely controlled with metformin.

@en

P2093

Adi Harbi Mohammad Khassawneh

http://www.w3.org/2001/XMLSchema#string

Ali Shakir Dauod

http://www.w3.org/2001/XMLSchema#string

Mousa Al Omari

http://www.w3.org/2001/XMLSchema#string

Othman Ahmed Beni Yonis

http://www.w3.org/2001/XMLSchema#string

Yousef Khader

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin: An Update

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes.

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

P304

29-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21556660.2016.1252379

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27994943

http://www.w3.org/2001/XMLSchema#string

P921

metformin

type-2 diabetes

P932

5136976

http://www.w3.org/2001/XMLSchema#string